104 related articles for article (PubMed ID: 3787456)
21. Simultaneous inhibition of the receptor kinase activity of vascular endothelial, fibroblast, and platelet-derived growth factors suppresses tumor growth and enhances tumor radiation response.
Griffin RJ; Williams BW; Wild R; Cherrington JM; Park H; Song CW
Cancer Res; 2002 Mar; 62(6):1702-6. PubMed ID: 11912143
[TBL] [Abstract][Full Text] [Related]
22. Tumor control by irradiation: A C3H-He mouse mammary carcinoma in mammary-tumor-agent-positive and mammary-tumor-agent-free mice.
Suit H; Kastelan A
J Natl Cancer Inst; 1968 May; 40(5):945-50. PubMed ID: 5648138
[No Abstract] [Full Text] [Related]
23. Changes of oxygen tension in experimental tumors after a single dose of X-ray irradiation.
Goda F; O'Hara JA; Rhodes ES; Liu KJ; Dunn JF; Bacic G; Swartz HM
Cancer Res; 1995 Jun; 55(11):2249-52. PubMed ID: 7757972
[TBL] [Abstract][Full Text] [Related]
24. Experimental studies on the radiation-modifying effect of bleomycin in malignant and normal mouse tissue in vivo.
Molin J; Søgaard PE; Overgaard J
Cancer Treat Rep; 1981; 65(7-8):583-9. PubMed ID: 6166372
[TBL] [Abstract][Full Text] [Related]
25. [Combined use of radiosensitizing and protective agents in experimental radiotherapy].
Magdon E; Schröder E; Iarmonenko SP; Vygodskaia AL; Vinskaia NP
Med Radiol (Mosk); 1984 Dec; 29(12):29-32. PubMed ID: 6513748
[TBL] [Abstract][Full Text] [Related]
26. [Comparative studies on the radiosensitizing action of 4-nitroimidazole and metronidazole (author's transl)].
Magdon E; Schröder E
Arch Geschwulstforsch; 1981; 51(3):225-30. PubMed ID: 7271431
[TBL] [Abstract][Full Text] [Related]
27. [Growth rate of experimental tumors in x-irradiation].
Mustafina RKh
Med Radiol (Mosk); 1984 Dec; 29(12):33-8. PubMed ID: 6513750
[TBL] [Abstract][Full Text] [Related]
28. The relative significance of repopulation and hypoxic clonogens in the fractionated radiotherapy of a mouse tumor.
Urano M; Nishimura Y; Yaes R
Radiat Res; 1995 May; 142(2):204-11. PubMed ID: 7724736
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel.
Milas L; Hunter NR; Mason KA; Kurdoglu B; Peters LJ
Cancer Res; 1994 Jul; 54(13):3506-10. PubMed ID: 7912167
[TBL] [Abstract][Full Text] [Related]
30. Initial comparative response of experimental tumors to peak pions and x rays.
Kligerman MM; DiCello JF; Davis HT; Thomas RA; Sternhagen CJ; Gomez L; Peterson DF
Radiology; 1975 Jul; 116(1):181-2. PubMed ID: 806096
[No Abstract] [Full Text] [Related]
31. Effects of tumors on the daily mitotic activity of mouse pars intermedia.
Surur JM; Catalano VA; Flamini MA; Barbeito CG
Cell Biol Int; 2005 Feb; 29(2):173-5. PubMed ID: 15774317
[TBL] [Abstract][Full Text] [Related]
32. Effects of irradiation by single or multiple fractions per day on transplantable murine mammary carcinoma.
Gonzalez Gonzalez D; Haveman J
Br J Radiol; 1982 Dec; 55(660):916-21. PubMed ID: 7171936
[TBL] [Abstract][Full Text] [Related]
33. Intraoral manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) radioprotective gene therapy decreases ionizing irradiation-induced murine mucosal cell cycling and apoptosis.
Epperly MW; Carpenter M; Agarwal A; Mitra P; Nie S; Greenberger JS
In Vivo; 2004; 18(4):401-10. PubMed ID: 15369176
[TBL] [Abstract][Full Text] [Related]
34. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
[TBL] [Abstract][Full Text] [Related]
35. Higher colon cancer tumor proliferative index and lower tumor cell death rate in mice undergoing laparotomy versus insufflation.
Lee SW; Gleason N; Blanco I; Asi ZK; Whelan RL
Surg Endosc; 2002 Jan; 16(1):36-9. PubMed ID: 11961601
[TBL] [Abstract][Full Text] [Related]
36. Evidence for paracrine regulation of experimental metastasis in 13762NF rat mammary adenocarcinoma cell clones.
Welch DR; Aeed PA; Earhart RH; McClure SA
Anticancer Res; 1994; 14(5A):1743-51. PubMed ID: 7847807
[TBL] [Abstract][Full Text] [Related]
37. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
38. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
39. Orgotein as a radioprotector in normal tissues. Experiments on mouse skin and a murine adenocarcinoma.
Cividalli A; Adami M; De Tomasi F; Palmisano L; Pardini MC; Spanò M; Mauro F
Acta Radiol Oncol; 1985; 24(3):273-7. PubMed ID: 2994380
[TBL] [Abstract][Full Text] [Related]
40. Radiation response and characteristics of a cell line derived from a mouse mammary adenocarcinoma.
Meyer KR; Hopwood LE; Gillette EL
Radiat Res; 1978 Feb; 73(2):315-29. PubMed ID: 565066
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
